Cardio Diagnostics Holdings, Inc. (CDIO)

NASDAQ: CDIO · Real-Time Price · USD

3.860

-0.028 (-0.72%)

At close: Sep 17, 2025, 4:00 PM EDT

3.900

+0.040 (1.04%)

Pre-market: Sep 18, 2025, 4:55 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Artificial Intelligence-driven DNA Biomarker Testing Technology	34.89K	Log In	Log In
Artificial Intelligence-driven DNA Biomarker Testing Technology Growth	104.45%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	34.89K	Log In	Log In
United States Growth	104.45%	Log In	Log In